#cancer-vaccines

#cancer-vaccines

After proving this concept across multiple studies, the team developed therapeutic cancer vaccines to tackle one of the most challenging targets yet - HPV-driven tumors. In a new study published in Science Advances, the scientists discovered that systematically changing the orientation and placement of a single cancer-targeting peptide can lead to formulations that supercharge the immune system's ability to attack tumors.